Gene Therapy for Usher Syndrome

July 11, 2017

Press Release: ProQR gets FDA orphan status designation for it's investigational drug QRX-411 for Usher Syndrome. Drug shows promise in pre-clinical studies.

 

Read more from AAO.org 

 

 

Share on Facebook
Share on Twitter
Please reload

Featured Review

Leadership Development for Women in STEM

September 21, 2019

1/10
Please reload

Tag Cloud

© 2017 by eyebytes 

  • Facebook Social Icon
  • LinkedIn Social Icon
  • Twitter Social Icon
  • Instagram Social Icon
This site was designed with the
.com
website builder. Create your website today.
Start Now